Litcius/Paper detail

Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern

Rajesh Vikkurthi, Asgar Ansari, Anupama Ramakanth Pai, Someshwar Nath Jha, Shilpa Sachan, Suvechchha Pandit, Bhushan Nikam, Anurag Kalia, Bimal Prasad Jit, Hilal Ahmad Parray, Savita Singh, Pallavi Kshetrapal, Nitya Wadhwa, Tripti Shrivastava, Poonam Coshic, Suresh Kumar, Pragya Sharma, Nandini Sharma, Juhi Taneja, Anil Kumar Pandey, Ashok Sharma, Ramachandran Thiruvengadam, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Shinjini Bhatnagar, Nimesh Gupta

2022Nature Microbiology57 citationsDOIOpen Access PDF

Topics & Concepts

Immune systemVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyCoronavirus disease 2019 (COVID-19)Immunological memory2019-20 coronavirus outbreakImmunologyImmunityMedicineDiseaseInfectious disease (medical specialty)OutbreakPathologySARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyViral Infections and Outbreaks Research
Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern | Litcius